Literature DB >> 7576940

Schwann cells in neuroblastoma.

I M Ambros1, P F Ambros.   

Abstract

Why should we consider Schwann cells when we are interested in the biology of neuroblastomas (NBs)? Although we are familiar with the term "stroma-rich" NB, we basically think of a favourable prognostic subgroup, histologically distinguished by the development of a prominent Schwann cell-stroma. According to current opinion on the maturation processes in NBs, the NB-associated Schwann cell is believed to represent a differentiation product of the NB cell, and we therefore do not envisage the Schwann cell as having any important role in NBs. However, our interest was raised after having realised that Schwann cells in NBs are normal cells, very likely attracted to the neoplastic neuroblasts. But what role does this cell play in these tumours? Can we still reduce the appearance of Schwann cells in NBs to an epi-phenomenon or is this cell population responsible for the differentiation of certain NBs? If so, will it be possible to use their strategies to induce differentiation of neuroblasts and so render them non-aggressive, mature ganglionic cells? To shed light on the possible interactions between normal Schwann cells and NB cells, the maturation capacity of NBs and the genetic constitution of the two main cell populations in these tumours are briefly reviewed. Some data leading to the current view on the origin of the Schwann cells in NBs, and several physiological aspects of the Schwann cells, including normal neurone-Schwann cell interactions, are detailed.

Entities:  

Mesh:

Year:  1995        PMID: 7576940     DOI: 10.1016/0959-8049(95)00051-j

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  8 in total

1.  WT1 expression is inversely correlated with MYCN amplification or expression and associated with poor survival in non-MYCN-amplified neuroblastoma.

Authors:  Caroline Masserot; Qingyuan Liu; Eric Nguyen; Charles-Henry Gattolliat; Dominique Valteau-Couanet; Jean Bénard; Catherine Huber; Evelyne Ségal-Bendirdjian
Journal:  Mol Oncol       Date:  2015-10-21       Impact factor: 6.603

2.  Immunohistochemical identification and comparison of glial cell lineage in foetal, neonatal, adult and neoplastic human adrenal medulla.

Authors:  G Magro; S Grasso
Journal:  Histochem J       Date:  1997-04

3.  Prognostic significance of the proliferative activity in neuroblastoma.

Authors:  P Rudolph; T Lappe; B Hero; F Berthold; R Parwaresch; D Harms; D Schmidt
Journal:  Am J Pathol       Date:  1997-01       Impact factor: 4.307

4.  Cross-talk between Schwann cells and neuroblasts influences the biology of neuroblastoma xenografts.

Authors:  Shuqing Liu; Yufeng Tian; Alexandre Chlenski; Qiwei Yang; Peter Zage; Helen R Salwen; Susan E Crawford; Susan L Cohn
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

5.  The neuroblastoma and ganglion components of nodular ganglioneuroblastoma are genetically similar: evidence against separate clonal origins.

Authors:  Paola Angelini; Sylvain Baruchel; Paula Marrano; Meredith S Irwin; Paul S Thorner
Journal:  Mod Pathol       Date:  2014-08-01       Impact factor: 7.842

6.  Reconstitution of Schwannian stroma in neuroblastomas using human bone marrow stromal cells.

Authors:  Wenlin Du; Nobumichi Hozumi; Michiie Sakamoto; Jun-ichi Hata; Taketo Yamada
Journal:  Am J Pathol       Date:  2008-09-04       Impact factor: 4.307

7.  Age Dependency of the Prognostic Impact of Tumor Genomics in Localized Resectable MYCN-Nonamplified Neuroblastomas. Report From the SIOPEN Biology Group on the LNESG Trials and a COG Validation Group.

Authors:  Inge M Ambros; Gian-Paolo Tonini; Ulrike Pötschger; Nicole Gross; Véronique Mosseri; Klaus Beiske; Ana P Berbegall; Jean Bénard; Nick Bown; Huib Caron; Valérie Combaret; Jerome Couturier; Raffaella Defferrari; Olivier Delattre; Marta Jeison; Per Kogner; John Lunec; Barbara Marques; Tommy Martinsson; Katia Mazzocco; Rosa Noguera; Gudrun Schleiermacher; Alexander Valent; Nadine Van Roy; Eva Villamon; Dasa Janousek; Ingrid Pribill; Evgenia Glogova; Edward F Attiyeh; Michael D Hogarty; Tom F Monclair; Keith Holmes; Dominique Valteau-Couanet; Victoria Castel; Deborah A Tweddle; Julie R Park; Sue Cohn; Ruth Ladenstein; Maja Beck-Popovic; Bruno De Bernardi; Jean Michon; Andrew D J Pearson; Peter F Ambros
Journal:  J Clin Oncol       Date:  2020-09-09       Impact factor: 44.544

8.  Expression of mRNA for the neurotrophin receptor trkC in neuroblastomas with favourable tumour stage and good prognosis.

Authors:  M Rydén; R Sehgal; C Dominici; F H Schilling; C F Ibáñez; P Kogner
Journal:  Br J Cancer       Date:  1996-09       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.